Thymosin Alpha-1 5mg
Investigational support for tissue-repair research.
Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide derived from the thymus gland, central to mature-T-cell development and immune-system regulation. It is one of the most extensively studied immunomodulatory peptides, with a literature spanning viral, oncology, and immune-deficiency research.
Proposed mechanism
Tα1 modulates T-cell maturation, NK-cell activity, and dendritic-cell function. It has been studied as an immune-system "primer" in models where immune function is compromised or where immune activation is a desired endpoint.
Research highlights
- 28-amino-acid thymus-derived peptide
- Decades of literature in immune-modulation research
- Studied across viral, oncology, and vaccine-adjuvant contexts
- Known pharmaceutically as thymalfasin (Zadaxin)
Research protocol notes
Reconstitute under sterile technique with bacteriostatic water. Typical volumes range from 1–3 mL depending on the target working concentration. Swirl gently — do not shake — to avoid peptide shearing.
Stacking and comparative studies
Typically studied alone in immune-research designs.
Handling and storage
Lyophilized powder is stable at ambient shipping temperatures. Once reconstituted with bacteriostatic water, store at 2–8 °C and use within 28 days. For long-term storage of unreconstituted vials, freeze at −20 °C and protect from light.
Frequently asked
Is Tα1 the same as thymalfasin?
Yes — thymalfasin is the pharmaceutical name for Thymosin Alpha-1. Sold pharmaceutically as Zadaxin in some markets.
How does it relate to Thymosin Beta-4?
Both are thymus-derived but work on different systems — Tα1 is immunomodulatory, Tβ4 (the parent of TB-500) is a cytoskeletal regulator active in repair.
What research contexts are most common?
Viral infection models, oncology immune-modulation, and vaccine-adjuvant research.
Is a COA included?
Yes — per-lot independent testing is standard.
